Observational studies and two randomized controlled trials consistently suggest that, in general, disease recurrence after ...

New findings reveal Black Americans face higher multiple sclerosis, ms rates and mortality while being systematically ...

A Phase 2a trial testing foralumab nasal spray in people with nonactive SPMS has dosed the first patients enrolled at Yale MS ...

A cancer diagnosis has hit very close to home in recent months. It’s likely that cancer has also struck close to most of ...

A decision on tolebrutinib for treating MS is now set for Sept. 28, after the FDA granted priority review to its approval ...

One of the tough things with multiple sclerosis is that it can take years sometimes for people to get diagnosed because the symptoms can be overlapping with other things or be somewhat vague.” ...

People living with MS, friends and family members and other supporters will lace up their walking shoes Sunday afternoon for ...

Multiple sclerosis, or MS affects a million Americans a year. It can lead to a range of symptoms. It’s a chronic illness that ...

2024 — Researchers have found a potential new way to improve the treatment of multiple sclerosis (MS) using a novel combined therapy. The results build on two harmonized Phase I clinical trials ...

Walk MS is two weeks away, and more than 1,500 people in the area are hard at work fundraising and building their teams.

Dr Pavan Bhargava shares AAN 2025 highlights, including anticipated presentations, quick takeaways, and insights into how new ...

Medicare covers many treatments for multiple sclerosis (MS) under different parts of Medicare. However, it does not cover experimental treatments. If you or a loved one has MS and are eligible for ...